Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes.
Endovascular therapy has increasingly become the initial clinical option for the treatment of lower-extremity peripheral arterial occlusive disease not only for patients with claudication but also for those with critical limb ischemia. Despite this major clinical practice paradigm shift, the outcomes of endovascular therapy for peripheral arterial disease are difficult to evaluate and compare with established surgical benchmarks because of the lack of prospective randomized trials, incomplete characterization of indications for intervention, mixing of arterial segments and extent of disease treated, the multiplicity of endovascular therapy techniques used, the exclusion of early treatment failures, crossover to open bypass during follow-up, and the frequent lack of intermediate and long-term patency and limb salvage rates in life-table format. These data limitations are especially problematic when one tries to assess the outcomes of endovascular therapy in patients with diabetes. The purpose of the present article is to succinctly review and objectively analyze available data regarding the results of endovascular therapy in patients with diabetes.
Ihnat
Daniel M
DM
Department of Vascular and Endovascular Surgery, University of Arizona Health Sciences Center, Tucson, AZ 85724, USA.
Mills
Joseph L
JL
D001157:Arterial Occlusive Diseases / Q000601:surgery*; D003925:Diabetic Angiopathies / Q000601:surgery*; D057510:Endovascular Procedures; D005263:Femoral Artery / Q000601:surgery; D006801:Humans; D007383:Intermittent Claudication / Q000601:surgery; D023821:Limb Salvage; D011150:Popliteal Artery / Q000601:surgery; D016896:Treatment Outcome; D014654:Vascular Patency